Epigenetic alterations have been recognized as important contributors to the pathogenesis of PDAC. However, the role of histone variants in pancreatic tumor progression is still not completely understood. The aim of this study was to explore the expression and prognostic significance of histone protein variants in PDAC patients. | Histone profiling reveals the histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma